Bal Pharma Stock

Bal Pharma EBIT Margin

The EBIT Margin (Operating Margin) of Bal Pharma (BALPHARMA.NS) as of Jul 23, 2026 is 6.53 %. In the previous year, EBIT Margin (Operating Margin) was 6.33 % — a change of 3.22% (higher).

EBIT Margin

6.53 %

YoY

3.22%

Last updated:

EBIT Margin (Operating Margin) of Bal Pharma is 2026 6.53 % . EBIT Margin (Operating Margin) of Bal Pharma was 2025 6.33 % . It decreases by 3.22% higher compared to the previous year.

For Bal Pharma, the operating (EBIT) margin of 6.5% is broadly stable versus 6.0% a few years ago.

Access this data via the Eulerpool API

Bal Pharma Stock analysis

What does Bal Pharma do? Bal Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bal Pharma stock

EBIT Margin (Operating Margin) of Bal Pharma is 6.53 % in 2026.

Access this data via the Eulerpool API

Margins — Bal Pharma

All Key Metrics — Bal Pharma